Hyperthermic intraperitoneal chemotherapy (HIPEC) is cost-effective in the management of primary ovarian cancer
- PMID: 30068488
- DOI: 10.1016/j.ygyno.2018.07.019
Hyperthermic intraperitoneal chemotherapy (HIPEC) is cost-effective in the management of primary ovarian cancer
Keywords: Cost-effectiveness; HIPEC; Ovarian cancer.
Similar articles
-
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.Ann Surg Oncol. 2023 Sep;30(9):5597-5609. doi: 10.1245/s10434-023-13757-0. Epub 2023 Jun 26. Ann Surg Oncol. 2023. PMID: 37358686 Review.
-
Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy.Gynecol Oncol. 2019 May;153(2):376-380. doi: 10.1016/j.ygyno.2019.01.025. Epub 2019 Feb 1. Gynecol Oncol. 2019. PMID: 30718126
-
State of the Science: The role of HIPEC in the treatment of ovarian cancer.Gynecol Oncol. 2021 Feb;160(2):364-368. doi: 10.1016/j.ygyno.2020.12.029. Epub 2021 Jan 6. Gynecol Oncol. 2021. PMID: 33419611 No abstract available.
-
Is There a Role for Intraperitoneal Chemotherapy, Including HIPEC, in the Management of Ovarian Cancer?J Clin Oncol. 2019 Sep 20;37(27):2420-2423. doi: 10.1200/JCO.19.00091. Epub 2019 Aug 12. J Clin Oncol. 2019. PMID: 31403870 Review. No abstract available.
-
Hyperthermic Intraperitoneal Chemotherapy after Secondary Cytoreduction in Epithelial Ovarian Cancer: A Single-center Comparative Analysis.Ann Surg Oncol. 2016 Apr;23(4):1294-301. doi: 10.1245/s10434-015-4991-4. Epub 2015 Dec 1. Ann Surg Oncol. 2016. PMID: 26628430 Clinical Trial.
Cited by
-
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Epithelial Ovarian Cancer: A 20-Year Single-Center Experience.Cancers (Basel). 2021 Jan 29;13(3):523. doi: 10.3390/cancers13030523. Cancers (Basel). 2021. PMID: 33572964 Free PMC article.
-
Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Overview of the Molecular and Cellular Mechanisms of Actions and Effects on Epithelial Ovarian Cancers.Int J Mol Sci. 2022 Sep 3;23(17):10078. doi: 10.3390/ijms231710078. Int J Mol Sci. 2022. PMID: 36077477 Free PMC article. Review.
-
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.Ann Surg Oncol. 2023 Sep;30(9):5597-5609. doi: 10.1245/s10434-023-13757-0. Epub 2023 Jun 26. Ann Surg Oncol. 2023. PMID: 37358686 Review.
-
Hyperthermic intraoperative peritoneal chemotherapy and cytoreductive surgery for people with peritoneal metastases: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2024 Sep;28(51):1-139. doi: 10.3310/KWDG6338. Health Technol Assess. 2024. PMID: 39254852 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical